Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
Protein

Cellular tumor antigen p53

Gene

Tp53

Organism
Rattus norvegicus (Rat)
Status
Reviewed-Annotation score: Annotation score: 5 out of 5-Experimental evidence at protein leveli

Functioni

Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seem to have to effect on cell-cycle regulation. Regulates the circadian clock by repressing CLOCK-ARNTL/BMAL1-mediated transcriptional activation of PER2.By similarity

Cofactori

Zn2+By similarityNote: Binds 1 zinc ion per subunit.By similarity

Sites

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Sitei118 – 1181Interaction with DNABy similarity
Metal bindingi174 – 1741ZincBy similarity
Metal bindingi177 – 1771ZincBy similarity
Metal bindingi236 – 2361ZincBy similarity
Metal bindingi240 – 2401ZincBy similarity

Regions

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
DNA bindingi100 – 290191By similarityAdd
BLAST

GO - Molecular functioni

GO - Biological processi

  • aging Source: RGD
  • cell aging Source: UniProtKB
  • cellular response to heat Source: RGD
  • cellular response to organonitrogen compound Source: RGD
  • cellular response to UV Source: GO_Central
  • circadian behavior Source: UniProtKB
  • DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator Source: GO_Central
  • DNA strand renaturation Source: UniProtKB
  • entrainment of circadian clock by photoperiod Source: UniProtKB
  • intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator Source: GO_Central
  • mitotic G1 DNA damage checkpoint Source: GO_Central
  • multicellular organismal development Source: UniProtKB
  • negative regulation of cell growth Source: UniProtKB
  • negative regulation of DNA biosynthetic process Source: RGD
  • negative regulation of smooth muscle cell proliferation Source: RGD
  • negative regulation of transcription, DNA-templated Source: UniProtKB
  • negative regulation of transcription from RNA polymerase II promoter Source: GO_Central
  • nucleotide-excision repair Source: UniProtKB
  • oligodendrocyte apoptotic process Source: UniProtKB
  • positive regulation of apoptotic process Source: RGD
  • positive regulation of cell cycle Source: RGD
  • positive regulation of histone deacetylation Source: GO_Central
  • positive regulation of leukocyte migration Source: RGD
  • positive regulation of neuron apoptotic process Source: GO_Central
  • positive regulation of release of cytochrome c from mitochondria Source: UniProtKB
  • positive regulation of transcription from RNA polymerase II promoter Source: BHF-UCL
  • protein tetramerization Source: InterPro
  • regulation of hydrogen peroxide-induced cell death Source: UniProtKB
  • regulation of intracellular pH Source: RGD
  • regulation of transcription from RNA polymerase II promoter Source: RGD
  • response to amino acid Source: RGD
  • response to caffeine Source: RGD
  • response to cytokine Source: RGD
  • response to drug Source: RGD
  • response to gamma radiation Source: GO_Central
  • response to hyperoxia Source: RGD
  • response to inorganic substance Source: RGD
  • response to metal ion Source: RGD
  • response to organic cyclic compound Source: RGD
  • response to organonitrogen compound Source: RGD
  • response to oxidative stress Source: RGD
  • response to retinoic acid Source: RGD
  • response to UV Source: RGD
  • response to UV-B Source: RGD
  • response to vitamin B3 Source: RGD
  • response to X-ray Source: RGD
  • transcription, DNA-templated Source: UniProtKB-KW
  • wound healing Source: RGD
Complete GO annotation...

Keywords - Molecular functioni

Activator, Repressor

Keywords - Biological processi

Apoptosis, Biological rhythms, Cell cycle, Necrosis, Transcription, Transcription regulation

Keywords - Ligandi

DNA-binding, Metal-binding, Zinc

Names & Taxonomyi

Protein namesi
Recommended name:
Cellular tumor antigen p53
Alternative name(s):
Tumor suppressor p53
Gene namesi
Name:Tp53
Synonyms:P53
OrganismiRattus norvegicus (Rat)
Taxonomic identifieri10116 [NCBI]
Taxonomic lineageiEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresGliresRodentiaSciurognathiMuroideaMuridaeMurinaeRattus
ProteomesiUP000002494 Componenti: Chromosome 10

Organism-specific databases

RGDi3889. Tp53.

Subcellular locationi

GO - Cellular componenti

  • chromatin Source: RGD
  • cytoplasm Source: UniProtKB
  • cytosol Source: RGD
  • endoplasmic reticulum Source: UniProtKB-SubCell
  • mitochondrial matrix Source: UniProtKB-SubCell
  • mitochondrion Source: UniProtKB
  • nucleolus Source: UniProtKB
  • nucleus Source: UniProtKB
  • replication fork Source: GO_Central
  • transcription factor complex Source: RGD
Complete GO annotation...

Keywords - Cellular componenti

Cytoplasm, Endoplasmic reticulum, Mitochondrion, Nucleus

Pathology & Biotechi

Involvement in diseasei

p53 is found in increased amounts in a wide variety of transformed cells. p53 is frequently mutated or inactivated in many types of cancer.

Keywords - Diseasei

Tumor suppressor

PTM / Processingi

Molecule processing

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Chaini1 – 391391Cellular tumor antigen p53PRO_0000185712Add
BLAST

Amino acid modifications

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Modified residuei9 – 91Phosphoserine; by HIPK4By similarity
Modified residuei15 – 151Phosphoserine; by CDK5, PRPK, AMPK, NUAK1 and ATMBy similarity
Modified residuei18 – 181Phosphothreonine; by CK1, VRK1 and VRK2By similarity
Modified residuei20 – 201Phosphoserine; by CHEK2, CK1 and PLK3By similarity
Modified residuei39 – 391Phosphoserine; by MAPKAPK5By similarity
Modified residuei118 – 1181N6-acetyllysine; by KAT6ABy similarity
Modified residuei181 – 1811Phosphoserine; by AURKBBy similarity
Modified residuei267 – 2671Phosphoserine; by AURKBBy similarity
Modified residuei282 – 2821Phosphothreonine; by AURKBBy similarity
Cross-linki289 – 289Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)By similarity
Cross-linki290 – 290Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)By similarity
Modified residuei303 – 3031N6-acetyllysineBy similarity
Modified residuei313 – 3131Phosphoserine; by AURKA, CDK1 and CDK2By similarity
Modified residuei319 – 3191N6-acetyllysineBy similarity
Modified residuei368 – 3681N6,N6-dimethyllysine; alternateBy similarity
Modified residuei368 – 3681N6-methyllysine; by SMYD2; alternateBy similarity
Modified residuei370 – 3701N6-methyllysine; by SETD7By similarity
Modified residuei371 – 3711N6,N6-dimethyllysine; by EHMT1 and EHMT2; alternateBy similarity
Modified residuei371 – 3711N6-acetyllysine; alternateBy similarity
Modified residuei379 – 3791N6-acetyllysineBy similarity
Modified residuei380 – 3801N6,N6-dimethyllysine; alternateBy similarity
Modified residuei380 – 3801N6-acetyllysine; by KAT6A; alternateBy similarity
Modified residuei380 – 3801N6-methyllysine; by SETD8; alternateBy similarity
Cross-linki384 – 384Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)By similarity
Modified residuei390 – 3901Phosphoserine; by CK2, CDK2 and NUAK1By similarity

Post-translational modificationi

Phosphorylation on Ser residues mediates transcriptional activation. Phosphorylation at Ser-9 by HIPK4 increases repression activity on BIRC5 promoter (By similarity). Phosphorylated on Thr-18 by VRK1, which may prevent the interaction with MDM2. Phosphorylated on Ser-20 by CHEK2 in response to DNA damage, which prevents ubiquitination by MDM2. Phosphorylated on Ser-20 by PLK3 in response to reactive oxygen species (ROS), promoting p53/TP53-mediated apoptosis. Probably phosphorylated on by CDK7 in a CAK complex in response to DNA damage. Phosphorylated by HIPK1. Phosphorylated on Ser-390 following UV but not gamma irradiation. Phosphorylated on Ser-15 upon ultraviolet irradiation; which is enhanced by interaction with BANP. Stabilized by CDK5-mediated phosphorylation in response to genotoxic and oxidative stresses at Ser-15, leading to accumulation of p53/TP53, particularly in the nucleus, thus inducing the transactivation of p53/TP53 target genes. Phosphorylated at Ser-313 and Ser-390 by CDK2 in response to DNA-damage (By similarity).By similarity
Acetylated. Its deacetylation by SIRT1 impairs its ability to induce proapoptotic program and modulate cell senescence. Deacetylation by SIRT2 impairs its ability to induce transcription activation in a AKT-dependent manner (By similarity).By similarity
Ubiquitinated by MDM2 and SYVN1, which leads to proteasomal degradation. Ubiquitinated by RFWD3, which works in cooperation with MDM2 and may catalyze the formation of short polyubiquitin chains on p53/TP53 that are not targeted to the proteasome. Ubiquitinated by MKRN1 at Lys-289 and Lys-290, which leads to proteasomal degradation. Deubiquitinated by USP10, leading to stabilize it. Ubiquitinated by TRIM24, RFFL and RNF34, which leads to proteasomal degradation. Ubiquitination by TOPORS induces degradation. Deubiquitination by USP7, leading to stabilize it. Ubiquitinated by RFWD2, which leads to proteasomal degradation. Ubiquitination and subsequent proteasomal degradation is negatively regulated by CCAR2 (By similarity).By similarity
Monomethylated at Lys-370 by SETD7, leading to stabilization and increased transcriptional activation. Monomethylated at Lys-368 by SMYD2, leading to decreased DNA-binding activity and subsequent transcriptional regulation activity. Lys-370 monomethylation prevents interaction with SMYD2 and subsequent monomethylation at Lys-368. Dimethylated at Lys-371 by EHMT1 and EHMT2. Monomethylated at Lys-380 by SETD8, promoting interaction with L3MBTL1 and leading to repress transcriptional activity. Demethylation of dimethylated Lys-368 by KDM1A prevents interaction with TP53BP1 and represses TP53-mediated transcriptional activation (By similarity).By similarity
Sumoylated with SUMO1. Sumoylated at Lys-384 by UBC9 (By similarity).By similarity

Keywords - PTMi

Acetylation, Isopeptide bond, Methylation, Phosphoprotein, Ubl conjugation

Proteomic databases

PaxDbiP10361.
PRIDEiP10361.

PTM databases

PhosphoSiteiP10361.

Expressioni

Gene expression databases

ExpressionAtlasiP10361. baseline and differential.
GenevisibleiP10361. RN.

Interactioni

Subunit structurei

Binds DNA as a homotetramer. Found in a complex with CABLES1 and TP73. Interacts with histone acetyltransferases EP300 and methyltransferases HRMT1L2 and CARM1, and recruits them to promoters. The C-terminus interacts with TAF1, when TAF1 is part of the TFIID complex. Interacts with HIPK1, HIPK2, AXIN1, and TP53INP1. Part of a complex consisting of TP53, HIPK2 and AXIN1. Interacts with WWOX. Interacts with USP7 and SYVN1. Interacts with BANP. Interacts with ARMD10, E4F1, CDKN2AIP, NUAK1, UHRF2 and STK11/LKB1. Interacts with CHD8, leading to recruit histone H1 and prevent transactivation activity (By similarity). Interacts with YWHAZ; the interaction enhances TP53 transcriptional activity. Phosphorylation of YWHAZ on 'Ser-58' inhibits this interaction (By similarity). Interacts with HSP90AB1. Directly interacts with FBXO42; leading to ubiquitination and degradation of TP53. Interacts with AURKA, DAXX, BRD7 and TRIM24. Interacts (when monomethylated at Lys-380) with L3MBTL1. Interacts with GRK5. Binds to the CAK complex (CDK7, cyclin H and MAT1) in response to DNA damage. Interacts with CDK5 in neurons. Interacts with AURKB, SETD2, UHRF2 and NOC2L. Interacts (via N-terminus) with PTK2/FAK1; this promotes ubiquitination by MDM2. Interacts with PTK2B/PYK2; this promotes ubiquitination by MDM2. Interacts with PRKCG. Interacts with PPIF; the association implicates preferentially tetrameric TP53, is induced by oxidative stress and is impaired by cyclosporin A (CsA). Interacts with SNAI1; the interaction induces SNAI1 degradation via MDM2-mediated ubiquitination and inhibits SNAI1-induced cell invasion (By similarity). Interacts with KAT6A (By similarity). Interacts with UBC9 (By similarity). Forms a complex with UBC9 and PRKRA (By similarity). Interacts with ZNF385B; the interaction is direct (By similarity). Interacts with ZNF385A; the interaction is direct and enhances p53/TP53 transactivation functions on cell-cycle arrest target genes, resulting in growth arrest (By similarity). Interacts with ANKRD2 (By similarity). Interacts with RFFL and RNF34; involved in p53/TP53 ubiquitination. Interacts with MTA1 and RFWD2. Interacts with CCAR2 (via N-terminus) (By similarity).By similarity

Protein-protein interaction databases

BioGridi246960. 9 interactions.
DIPiDIP-46016N.
IntActiP10361. 4 interactions.
MINTiMINT-4651801.
STRINGi10116.ENSRNOP00000047840.

Structurei

3D structure databases

ProteinModelPortaliP10361.
SMRiP10361. Positions 93-288, 317-358.
ModBaseiSearch...
MobiDBiSearch...

Family & Domainsi

Region

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Regioni1 – 318318Interaction with CCAR2By similarityAdd
BLAST
Regioni1 – 4747Transcription activation (acidic)Add
BLAST
Regioni64 – 10845Interaction with WWOXBy similarityAdd
BLAST
Regioni98 – 368271Interaction with HIPK1By similarityAdd
BLAST
Regioni98 – 298201Required for interaction with ZNF385ABy similarityAdd
BLAST
Regioni111 – 234124Required for interaction with FBXO42By similarityAdd
BLAST
Regioni114 – 290177Interaction with AXIN1By similarityAdd
BLAST
Regioni254 – 29239Interaction with E4F1By similarityAdd
BLAST
Regioni271 – 2788Interaction with DNABy similarity
Regioni317 – 35842Interaction with HIPK2By similarityAdd
BLAST
Regioni323 – 35432OligomerizationAdd
BLAST
Regioni357 – 3615Interaction with USP7By similarity
Regioni366 – 38520Basic (repression of DNA-binding)Add
BLAST

Motif

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Motifi303 – 31917Bipartite nuclear localization signalBy similarityAdd
BLAST
Motifi337 – 34812Nuclear export signalBy similarityAdd
BLAST
Motifi368 – 3703[KR]-[STA]-K motif

Domaini

The [KR]-[STA]-K motif is specifically recognized by the SETD7 methyltransferase.By similarity

Sequence similaritiesi

Belongs to the p53 family.Curated

Phylogenomic databases

eggNOGiNOG80479.
GeneTreeiENSGT00390000015092.
HOGENOMiHOG000039957.
HOVERGENiHBG005201.
InParanoidiP10361.
KOiK04451.
OMAiVVSTRIC.
OrthoDBiEOG7JQBNW.
PhylomeDBiP10361.
TreeFamiTF106101.

Family and domain databases

Gene3Di2.60.40.720. 1 hit.
4.10.170.10. 1 hit.
InterProiIPR008967. p53-like_TF_DNA-bd.
IPR012346. p53/RUNT-type_TF_DNA-bd.
IPR011615. p53_DNA-bd.
IPR010991. p53_tetrameristn.
IPR013872. p53_transactivation_domain.
IPR002117. p53_tumour_suppressor.
[Graphical view]
PANTHERiPTHR11447. PTHR11447. 1 hit.
PfamiPF00870. P53. 1 hit.
PF08563. P53_TAD. 1 hit.
PF07710. P53_tetramer. 1 hit.
[Graphical view]
PRINTSiPR00386. P53SUPPRESSR.
SUPFAMiSSF47719. SSF47719. 1 hit.
SSF49417. SSF49417. 1 hit.
PROSITEiPS00348. P53. 1 hit.
[Graphical view]

Sequencei

Sequence statusi: Complete.

P10361-1 [UniParc]FASTAAdd to basket

« Hide

        10         20         30         40         50
MEDSQSDMSI ELPLSQETFS CLWKLLPPDD ILPTTATGSP NSMEDLFLPQ
60 70 80 90 100
DVAELLEGPE EALQVSAPAA QEPGTEAPAP VAPASATPWP LSSSVPSQKT
110 120 130 140 150
YQGNYGFHLG FLQSGTAKSV MCTYSISLNK LFCQLAKTCP VQLWVTSTPP
160 170 180 190 200
PGTRVRAMAI YKKSQHMTEV VRRCPHHERC SDGDGLAPPQ HLIRVEGNPY
210 220 230 240 250
AEYLDDRQTF RHSVVVPYEP PEVGSDYTTI HYKYMCNSSC MGGMNRRPIL
260 270 280 290 300
TIITLEDSSG NLLGRDSFEV RVCACPGRDR RTEEENFRKK EEHCPELPPG
310 320 330 340 350
SAKRALPTST SSSPQQKKKP LDGEYFTLKI RGRERFEMFR ELNEALELKD
360 370 380 390
ARAAEESGDS RAHSSYPKTK KGQSTSRHKK PMIKKVGPDS D
Length:391
Mass (Da):43,451
Last modified:July 1, 1989 - v1
Checksum:iE62522313A5C872F
GO

Experimental Info

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Sequence conflicti174 – 1741C → W in AAA41788 (PubMed:8441680).Curated

Natural variant

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Natural varianti103 – 1031G → S.
Natural varianti256 – 2561E → G.

Sequence databases

Select the link destinations:
EMBLi
GenBanki
DDBJi
Links Updated
X13058 mRNA. Translation: CAA31457.1.
L07910
, L07904, L07905, L07906, L07907, L07908, L07909 Genomic DNA. Translation: AAA41788.1.
U90328 mRNA. Translation: AAB80959.1.
BC081788 mRNA. Translation: AAH81788.2.
BC098663 mRNA. Translation: AAH98663.1.
PIRiS02192.
RefSeqiNP_112251.2. NM_030989.3.
XP_006246656.1. XM_006246594.2.
XP_006246657.1. XM_006246595.2.
UniGeneiRn.54443.

Genome annotation databases

EnsembliENSRNOT00000046490; ENSRNOP00000047840; ENSRNOG00000010756.
ENSRNOT00000085115; ENSRNOP00000074031; ENSRNOG00000010756.
GeneIDi24842.
KEGGirno:24842.
UCSCiRGD:3889. rat.

Cross-referencesi

Sequence databases

Select the link destinations:
EMBLi
GenBanki
DDBJi
Links Updated
X13058 mRNA. Translation: CAA31457.1.
L07910
, L07904, L07905, L07906, L07907, L07908, L07909 Genomic DNA. Translation: AAA41788.1.
U90328 mRNA. Translation: AAB80959.1.
BC081788 mRNA. Translation: AAH81788.2.
BC098663 mRNA. Translation: AAH98663.1.
PIRiS02192.
RefSeqiNP_112251.2. NM_030989.3.
XP_006246656.1. XM_006246594.2.
XP_006246657.1. XM_006246595.2.
UniGeneiRn.54443.

3D structure databases

ProteinModelPortaliP10361.
SMRiP10361. Positions 93-288, 317-358.
ModBaseiSearch...
MobiDBiSearch...

Protein-protein interaction databases

BioGridi246960. 9 interactions.
DIPiDIP-46016N.
IntActiP10361. 4 interactions.
MINTiMINT-4651801.
STRINGi10116.ENSRNOP00000047840.

PTM databases

PhosphoSiteiP10361.

Proteomic databases

PaxDbiP10361.
PRIDEiP10361.

Protocols and materials databases

Structural Biology KnowledgebaseSearch...

Genome annotation databases

EnsembliENSRNOT00000046490; ENSRNOP00000047840; ENSRNOG00000010756.
ENSRNOT00000085115; ENSRNOP00000074031; ENSRNOG00000010756.
GeneIDi24842.
KEGGirno:24842.
UCSCiRGD:3889. rat.

Organism-specific databases

CTDi7157.
RGDi3889. Tp53.

Phylogenomic databases

eggNOGiNOG80479.
GeneTreeiENSGT00390000015092.
HOGENOMiHOG000039957.
HOVERGENiHBG005201.
InParanoidiP10361.
KOiK04451.
OMAiVVSTRIC.
OrthoDBiEOG7JQBNW.
PhylomeDBiP10361.
TreeFamiTF106101.

Miscellaneous databases

NextBioi604596.
PROiP10361.

Gene expression databases

ExpressionAtlasiP10361. baseline and differential.
GenevisibleiP10361. RN.

Family and domain databases

Gene3Di2.60.40.720. 1 hit.
4.10.170.10. 1 hit.
InterProiIPR008967. p53-like_TF_DNA-bd.
IPR012346. p53/RUNT-type_TF_DNA-bd.
IPR011615. p53_DNA-bd.
IPR010991. p53_tetrameristn.
IPR013872. p53_transactivation_domain.
IPR002117. p53_tumour_suppressor.
[Graphical view]
PANTHERiPTHR11447. PTHR11447. 1 hit.
PfamiPF00870. P53. 1 hit.
PF08563. P53_TAD. 1 hit.
PF07710. P53_tetramer. 1 hit.
[Graphical view]
PRINTSiPR00386. P53SUPPRESSR.
SUPFAMiSSF47719. SSF47719. 1 hit.
SSF49417. SSF49417. 1 hit.
PROSITEiPS00348. P53. 1 hit.
[Graphical view]
ProtoNetiSearch...

Publicationsi

« Hide 'large scale' publications
  1. "Nucleotide sequence of a cDNA encoding the rat p53 nuclear oncoprotein."
    Soussi T.
    Nucleic Acids Res. 16:11384-11384(1988) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA].
  2. "Structure of the rat p53 tumor suppressor gene."
    Hulla J.E., Schneider R.P.
    Nucleic Acids Res. 21:713-717(1993) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
  3. "Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53."
    Mathupala S.P., Heese C., Pedersen P.L.
    J. Biol. Chem. 272:22776-22780(1997) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA].
    Strain: Sprague-Dawley.
  4. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
    Tissue: Heart and Thymus.
  5. "Heat shock protein 84 forms a complex with mutant p53 protein predominantly within a cytoplasmic compartment of the cell."
    Sepehrnia B., Paz I.B., Dasgupta G., Momand J.
    J. Biol. Chem. 271:15084-15090(1996) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH HSP90AB1.
    Tissue: Embryo.
  6. "p53 opens the mitochondrial permeability transition pore to trigger necrosis."
    Vaseva A.V., Marchenko N.D., Ji K., Tsirka S.E., Holzmann S., Moll U.M.
    Cell 149:1536-1548(2012) [PubMed] [Europe PMC] [Abstract]
    Cited for: SUBCELLULAR LOCATION.

Entry informationi

Entry nameiP53_RAT
AccessioniPrimary (citable) accession number: P10361
Secondary accession number(s): O09168, Q4KMA9, Q66HM0
Entry historyi
Integrated into UniProtKB/Swiss-Prot: July 1, 1989
Last sequence update: July 1, 1989
Last modified: July 22, 2015
This is version 178 of the entry and version 1 of the sequence. [Complete history]
Entry statusiReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program

Miscellaneousi

Keywords - Technical termi

Complete proteome, Reference proteome

Documents

  1. SIMILARITY comments
    Index of protein domains and families

External Data

Dasty 3

Similar proteinsi

Links to similar proteins from the UniProt Reference Clusters (UniRef) at 100%, 90% and 50% sequence identity:
100%UniRef100 combines identical sequences and sub-fragments with 11 or more residues from any organism into Uniref entry.
90%UniRef90 is built by clustering UniRef100 sequences that have at least 90% sequence identity to, and 80% overlap with, the longest sequence (a.k.a seed sequence).
50%UniRef50 is built by clustering UniRef90 seed sequences that have at least 50% sequence identity to, and 80% overlap with, the longest sequence in the cluster.